miR-221 and miR-222 simultaneously target RECK and regulate growth and invasion of gastric cancer cells

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 2718-2725

  Liu, Wenneng ^a   Song, Nian ^b   Yao, Huihua ^b   Zhao, Liying ^a   Liu, Hao ^a   Li, Guoxin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Department of Orthopaedics   (China)

Author keywords

Helicobacter pylori; MicroRNAs; Stomach neoplasms

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; MICRORNA 221; MICRORNA 222; PEPTIDES AND PROTEINS; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIFS; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MICRORNA; MIRN221 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN; RECK PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL INVASION; CELL INVASION ASSAY; CELL VIABILITY ASSAY; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ADENOCARCINOMA; CELL SURVIVAL; CELL TRANSFORMATION; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HELICOBACTER PYLORI; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; STOMACH TUMOR; TUMOR INVASION;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; ADULT; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HEK293 CELLS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS;

EID: 84941330336     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.894324     Document Type: Article

References (22)

1. Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. Cancer J Clin, 2014; 64(1): 9–29
2. Asaka M, Sepulveda AR, Sugiyama T, Graham DY: Gastric Cancer. In: Helicobacter pylori: physiology and genetics. Mobley HLT, Mendz GL, Hazell SL (eds.), Washington (DC), 2001
3. Graham DY: Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015; 148(4):719–31.
4. Wang J, Wang Q, Liu H et al: MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer. Cancer Lett, 2010; 297(2): 137–43
5. Zhou X, Xu G, Yin C et al: Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK. Oncotarget, 2014; 5(22): 11631–40
6. Zhou X, Li L, Su J, Zhang G: Decreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4. PloS One, 2014; 9(7), 101457
7. Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A et al: miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer, 2011; 10: 29
8. Ma L, Chen Y, Zhang B, Liu G: Increased microRNA-223 in Helicobacter pylori- associated gastric cancer contributed to cancer cell proliferation and migration. Biosci Biotechnol Biochem, 2014; 78(4): 602–8
9. Li N, Tang B, Zhu ED et al: Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett, 2012; 586(6): 722–28
10. Zhang Z, Li Z, Gao C et al: miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest, 2008; 88(12): 1358–66
11. Song SY, Son HJ, Nam E et al: Expression of reversion-inducing-cysteinerich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer. Eur J Cancer, 2006; 42(1): 101–8
12. Zhao H, Wang Y, Yang L et al: MiR-25 promotes gastric cancer cells growth and motility by targeting RECK. Mol Cell Biochem, 2014; 385(1–2): 207–13
13. Xie J, Tan ZH, Tang X et al: MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. World J Gastroenterol, 2014; 20(46): 17439–47
14. Clark JC, Thomas DM, Choong PF, Dass CR: RECK–a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev, 2007; 26(3–4): 675–83
15. Wang M, Zhao C, Shi H et al: Deregulated microRNAs in gastric cancer tissue- derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer, 2014; 110(5): 1199–210
16. Fu Z, Qian F, Yang X et al: Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer. Med Oncol, 2014; 31(9): 164
17. Chun-Zhi Z, Lei H, An-Ling Z et al: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer, 2010; 10: 367
18. Noda M, Oh J, Takahashi R et al: RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev, 2003; 22(2–3): 167–75
19. Murai R, Yoshida Y, Muraguchi T et al: A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasissuppressing anticancer drugs. Oncotarget, 2010; 1(4): 252–64
20. Du YY, Dai DQ, Yang Z: Role of RECK methylation in gastric cancer and its clinical significance. World J Gastroenterol, 2010; 16(7): 904–8
21. Takahashi C, Sheng Z, Horan TP et al: Regulation of matrix metalloproteinase- 9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA, 1998; 95(22): 13221–26
22. Hong KJ, Wu DC, Cheng KH et al: RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation. J Cell Physiol, 2014; 229(2): 191–201